The Dow Jones Industrial Average and other key Wall Street indexes held steady Monday as President Donald Trump met European leaders and Ukrainian President Volodymyr Zelenskyy. Solar stocks such as Sunrun and Array Technologies climbed, while education stock Stride cleared an entry. Also, a new Warren Buffett stock rallied once again on the stock market today.
The Dow finished the day down 34 points, or less than 0.1%. Sherwin-Williams lost the most on the blue chip index with a dip of nearly 2%. Meanwhile, Walt Disney, Cisco Systems and Nvidia were among the better performers.
The Nasdaq composite managed to finish the day with a nominal gain, as it avoided another distribution day. Shares of Palantir Technologies and Electronic Arts fell roughly 2% and 3%, respectively. Top performers on the tech-heavy index included Trade Desk, which jumped more than 5%.
Stock Market Today: Consumer Discretionary Outperforms
The S&P 500 was just a shade lower as the benchmark index's sectors were mixed on the stock market today. Consumer discretionary and industrials fared best while communication services and real estate lagged.
Dayforce catapulted 26% higher following a Bloomberg report that private equity firm Thoma Bravo is in talks to buy the maker of software for human resources management. Energy stock EQT lagged, sliding more than 4%.
Volume was mixed, rising on the Nasdaq while falling on the New York Stock Exchange, according to preliminary data.
Small caps were outperforming, with the Russell 2000 index up 0.4%. Growth stocks reversed higher, with the Innovator IBD 50 exchange traded fund up 0.1%. The fund's gain for 2025 still sits at around 21%.
The 10-year Treasury yield edged higher to 4.34%. Oil prices rose, with West Texas Intermediate futures up nearly 1% to $63.34 per barrel.
New Warren Buffett Stock Pops Again
Last week, Warren Buffett-led Berkshire Hathaway made a number of fresh stock market purchases. The firm loaded up on UnitedHealth, snapping up 5 million shares, prompting the stock to pop 12% Friday. UnitedHealth added 1.5% on the stock market today, but remained off the day's highs.
The stock has a Composite Rating of just 22 out of 99 from Investor's Business Daily. While the stock has retaken its 50-day moving average, it remains around 30% below the 200-day line. It is down nearly 39% so far this year.
While UnitedHealth may appeal to value investors like Buffett, it does not meet the criteria sought by those following IBD investing principles.
One new Buffett addition perhaps worth adding to a watchlist is D.R. Horton. This was formerly a mystery stock, which allowed Buffett to build up a stake of about 1.5 million shares in the homebuilder over the prior two quarters.
The stock is forming a cup base with an ideal buy point of 199.85, according to MarketSurge analysis. At the moment it has an IBD Composite Rating of 75, which is not ideal. Earnings performance is a key weakness here, with its Earnings Per Share Rating sitting at 54 out of 99.
Horton's fellow homebuilder Lennar and Nucor were the other mystery stocks unveiled by Berkshire in its latest 13F filing.
3:11 p.m. ET
Trump Teases Putin Move After Ukraine Meeting
President Donald Trump held a meeting with European leaders and his Ukrainian counterpart Volodymyr Zelenskyy at the White House Monday. It comes after the American leader met Russian President Vladimir Putin in Alaska on Friday.
The two met to discuss a way to end the Russia-Ukraine war, which has been raging since February 2022. Trump struck an optimistic tone, though he now says he does not see a need for a temporary ceasefire before negotiating an end to the conflict.
Zelenskyy highlighted the importance of U.S. security guarantees, while Trump said that "we'll help them out with that" as it is "very important to get the deal done."
An end to the conflict could lift an overhang on markets, particularly for the energy sector. Trump also said that he would be having a "phone call right after these meetings today" with Putin as he tries to bring the conflict to a close.
TeraWulf Tests This Level After Google Move
TeraWulf has been on a powerful run in recent sessions, and it was turning in even more gains on the stock market today. The bitcoin miner and artificial intelligence play rallied on news that Google-parent Alphabet is raising its investment in the firm to around $3.2 billion.
The search giant is pouring more money into the company to help finance the expansion of TeraWulf's Lake Mariner data center campus. This, in turn, is to support Google-backed Fluidstack, which builds and operates high-performance graphics processing unit clusters. The latter firm exercised an option to expand at TeraWulf's campus.
Google will provide an incremental backstop of $1.4 billion to support debt financing. In exchange, Google is getting warrants for 32.5 million shares of TeraWulf stock. It now owns about 14% in the company.
TeraWulf soared nearly 11% on the stock market today, though it was off session highs. It is up and is currently testing the 10 level, which is a key resistance level to watch.
TeraWulf has rocketed by a remarkable 92% over the past four weeks and gained more than 75% so far this year.
2:07 p.m. ET
Medical Sector Leader Tests Buy Point
With IBD continuing to recommend stock market exposure at the 80%-to-100% level, it is crucial to keep track of strong stocks clearing entries.
Medical products play Insulet is certainly one to keep on eye on, given it is an IBD Sector Leader. This is IBD's most stringent and powerful screen.
The Massachusetts-based diabetes medtech company's stock briefly punched its way above a cup-with-handle base entry of 322.80, though it is back below this level for now.
Monday's move was coming in on below-average volume, however, which is a reason to be cautious.
Nevertheless, the stock is an outstanding all-around performer, with its IBD Composite Rating sitting at 97.
Insulet has rallied by around 23% so far in 2025. Earnings are its strongest suit though, with profits popping by an average 54% over the past three quarters. Per-share earnings are also accelerating.
Last month, William Blair analyst Brandon Vazquez reiterated his outperform rating on Insulet stock. The stock has a consensus rating of strong buy with an average price target of 359.44, according to TipRanks.
12:47 p.m. ET
Stock Market Today: Education Play Stride Clears Entry
One stock that was pacing higher on the stock market today was education play Stride.
It rose nearly 2%, which was enough for it to test a consolidation entry of 162.30.
The relative strength line is moving sharply higher, and its 10-day line recently bullishly cleared the 21-day exponential moving average.
Overall performance here is very good, with Stride stock holding an IBD Composite Rating of 97.
Fundamental performance is a key strength, as it holds a best-possible EPS Rating of 99. The stock has been making strong gains of late, rising around 56% so far this year.
In addition, its B- Accumulation/Distribution Rating reflects institutional buying of late.
In total, 70% of the stock is held by funds. Noteworthy holders include the Lord Abbett Developing Growth Fund (LAGWX).
Stride is an online educational company. In addition to providing alternative programs to on-campus schooling it also operates virtual charter schools. It partners with nonprofits and also runs state-funded programs.
11:41 a.m. ET
Novo Nordisk Jumps On New Wegovy Approval
Novo Nordisk popped 5% on the stock market today on positive news around its obesity drug Wegovy. It has received approval from the U.S. Food and Drug Administration for use as a treatment for metabolic dysfunction-associated steatohepatitis.
This is a serious liver disease which is characterized by fat buildup around the organ. It is often linked to obesity and diabetes. It happens because sufferers have excess fat cells in their livers, according to the Cleveland Clinic.
But while the stock was making a strong move Monday, it remains stuck below its 50-day and 200-day moving averages.
And despite the fact it holds a strong Earnings Per Share Rating of 96 out of 99, it is down nearly 37% so far in 2025. However, it is trying to fight back from recent lows.
10:35 a.m. ET
Solar Stocks Run Higher On This
Solar stocks were shining in early action Monday after the Treasury Department issued new guidance on how renewable projects might qualify for tax benefits. The fresh clean energy tax-credit guidance proved less punitive than expected, which gave the equities a boost.
It replaced a previous 5% capital expenditure requirement for a project to qualify, and now projects must begin "physical work of a significant nature" by July 5, 2026. According to JPMorgan analysts, there had been worries the Trump administration could actually increase the 5% capital expenditure threshold.
Sunrun soared nearly 10% on the stock market today, and now sits clear of its short-term and major moving averages.
Also, Array Technologies jumped more than 8%. It moved clear of a double-bottom base entry of 8.19, MarketSurge analysis shows. It holds a Composite Rating of 93 out of 99 from Investor's Business Daily. However, IBD does not recommend buying stocks that are priced below the 10 level.
First Solar surged nearly 9% and is now extended past a 189.50 entry. Nextracker leaped more than 9%. It popped higher above its 50-day moving average and tested an alternate entry of 65.66.
SolarEdge Technologies popped out the gate, though gains faded to a lift of around 1%.
9:43 a.m. ET
Nasdaq 100 Winners, Losers: Lululemon, Meta Platforms
Inside the Nasdaq 100, Lululemon Athletica and PDD were among the best performers in early morning action. Lululemon stock rose nearly 3%, while PDD gained 0.5%.
On the downside, Intel plunged nearly 5% while Meta dropped more than 3% after the market open.
8:29 a.m. ET
Stock Market Today: Novo Nordisk Rallies On Wegovy FDA Approval
Late Friday, Novo Nordisk said the company's blockbuster Wegovy weight-loss drug received accelerated approval from the U.S. Food and Drug Administration to treat a serious liver disease.
Novo stock rallied 4% premarket Monday. But shares remain around 60% off their 52-week high.
8:04 a.m. ET
Dow Jones Movers: Amazon, Merck, Nvidia, UnitedHealth,
Inside the Dow Jones Industrial Average, Amazon.com, Merck, Nvidia and UnitedHealth Group were early morning movers.
Amazon stock fell 0.3%, threatening to snap a four-day win streak, while Merck shares climbed 0.3% in morning action. Nvidia stock eased 0.3%, set to extend Friday's losses. And UnitedHealth stock jumped 2.4%, looking to add to Friday's 12% Warren Buffett-fueled surge.
Stock Market Today: Powell Speech Looms
Walmart and Home Depot will lead a slew of retail earnings reports this week.
But the economic highlight of the week is expected to be the annual Jackson Hole speech Friday morning from Fed chief Powell.
In the past, Powell has used the event to signal key policy changes in prior years. Markets will be looking to see if he confirms market expectations of Fed rate cuts.
The odds of a rate cut at the Fed's Sept. 17 meeting are around 85%, but that's down from a virtual lock before some hot inflation and economic data this past week. Investors are betting on another cut by year's end, with a decent chance of a third.
Please follow Michael Larkin on X at @IBD_MLarkin for more analysis of growth stocks.
Also, be sure to follow Scott Lehtonen on X at @IBD_SLehtonen for more on growth stocks, the Dow Jones Industrial Average and the stock market today.
